The company said it had granted incentive stock options to certain officers, directors and consultants
Inc () said Thursday that it has granted stock options to certain officers, directors and consultants, pursuant to its 10% rolling stock option plan.
The company said certain officers, directors and consultants will be entitled to purchase a total of 4,900,000 common shares of the company at an exercise price of C$0.05 per share for a three-year-term.
The company said the term will expire on February 7, 2022.
Lean Life Health develops omega-3 products which can be formulated as liquids, emulsions or powders and used as food additives
Shares of LeanLife were up 11.1% at C$0.05 on Thursday.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of LeanLife Health named herein, including the promotion by the Company of LeanLife Health in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HERE